Epidemiology, laboratory diagnosis and clinical aspects of fungal pulmonary infections in 384 patients hospitalized in pulmonary units in Guilan province, Iran.
Bronchoalveolar lavage
Candidiasis
Fungal respiratory infections
Galactomannan antigen
Invasive pulmonary aspergillosis
Sputum
Journal
Iranian journal of microbiology
ISSN: 2008-3289
Titre abrégé: Iran J Microbiol
Pays: Iran
ID NLM: 101518404
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
entrez:
30
9
2020
pubmed:
1
10
2020
medline:
1
10
2020
Statut:
ppublish
Résumé
The respiratory tract is the most common site for developing fungal infections. People who have a weakened immune system are more susceptible to respiratory system involvement with fungi. Fungal infections of the respiratory tract are largely unrecognized and their true burden is elusive. Therefore, the aim of the current study was to evaluate the clinical spectrum, demographic characteristics, risk factors, and etiology of fungal respiratory infections in 384 patients hospitalized in pulmonary units of Razi hospital, Guilan province, Iran. A total of 384 lung specimens (192 Bronchoalveolar lavages (BAL) and 192 sputa) were obtained from patients who met the inclusion criteria. All samples were analyzed by direct microscopy and culture. Fungal identification was accomplished by internal transcribed spacer (ITS) and beta-tubulin sequencing. Also, in patients suspected to invasive pulmonary aspergillosis BAL specimens were tested for galactomannan (GM) antigen. According to the host factors (clinical symptoms, radiology findings and predisposing factors which were defined as inclusion criteria), and the positive results in direct examination, culture and serology (GM for aspergillosis) the infection was confirmed. Fungal respiratory infection was confirmed in 137 cases (35.67%) including 86 (62.77%) males and 51 (37.23%) females and the highest prevalence of infection was found in the age group of 46-72 years (n=75, 54.74%). Cough (n=129, 94.16%), dyspnea (n=111, 81.02%), purulent sputum (n=85, 62.04%) and weight loss (n=77, 56.2%) were the predominant symptoms. Tuberculosis (n=34, 24.81%), taking chemotherapy regimen (n=30, 21.89%) and diabetes mellitus (n=27, 19.70%) were the predominant underlying conditions. According to the results of this study, infected infants with congenital CMV infection could identify at early stage by testing Guthrie cards (within 21 days of life). Furthermore, since there is a lack of CMV knowledge in our population, educating and effective counseling by obstetricians/gynecologists to the pregnant women are recommended.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
The respiratory tract is the most common site for developing fungal infections. People who have a weakened immune system are more susceptible to respiratory system involvement with fungi. Fungal infections of the respiratory tract are largely unrecognized and their true burden is elusive. Therefore, the aim of the current study was to evaluate the clinical spectrum, demographic characteristics, risk factors, and etiology of fungal respiratory infections in 384 patients hospitalized in pulmonary units of Razi hospital, Guilan province, Iran.
MATERIALS AND METHODS
METHODS
A total of 384 lung specimens (192 Bronchoalveolar lavages (BAL) and 192 sputa) were obtained from patients who met the inclusion criteria. All samples were analyzed by direct microscopy and culture. Fungal identification was accomplished by internal transcribed spacer (ITS) and beta-tubulin sequencing. Also, in patients suspected to invasive pulmonary aspergillosis BAL specimens were tested for galactomannan (GM) antigen. According to the host factors (clinical symptoms, radiology findings and predisposing factors which were defined as inclusion criteria), and the positive results in direct examination, culture and serology (GM for aspergillosis) the infection was confirmed.
RESULTS
RESULTS
Fungal respiratory infection was confirmed in 137 cases (35.67%) including 86 (62.77%) males and 51 (37.23%) females and the highest prevalence of infection was found in the age group of 46-72 years (n=75, 54.74%). Cough (n=129, 94.16%), dyspnea (n=111, 81.02%), purulent sputum (n=85, 62.04%) and weight loss (n=77, 56.2%) were the predominant symptoms. Tuberculosis (n=34, 24.81%), taking chemotherapy regimen (n=30, 21.89%) and diabetes mellitus (n=27, 19.70%) were the predominant underlying conditions.
CONCLUSION
CONCLUSIONS
According to the results of this study, infected infants with congenital CMV infection could identify at early stage by testing Guthrie cards (within 21 days of life). Furthermore, since there is a lack of CMV knowledge in our population, educating and effective counseling by obstetricians/gynecologists to the pregnant women are recommended.
Identifiants
pubmed: 32994908
doi: 10.18502/ijm.v12i4.3940
pii: ijm-12-353
pmc: PMC7502145
doi:
Types de publication
Journal Article
Langues
eng
Pagination
353-363Informations de copyright
Copyright© 2020 Iranian Society of Microbiology & Tehran University of Medical Sciences.
Références
Lancet Infect Dis. 2002 Nov;2(11):659-66
pubmed: 12409046
Microb Pathog. 2018 Mar;116:296-300
pubmed: 29410233
J Microbiol Immunol Infect. 2007 Apr;40(2):148-53
pubmed: 17446963
Colomb Med (Cali). 2016 Jun 30;47(2):105-8
pubmed: 27546933
Trends Microbiol. 2004 Jan;12(1):44-9
pubmed: 14700551
Proc Am Thorac Soc. 2005;2(5):445-8
pubmed: 16322598
Mikrobiyol Bul. 2009 Jul;43(3):499-506
pubmed: 19795628
J Clin Microbiol. 1995 Jul;33(7):1912-4
pubmed: 7665670
Biomed Res Int. 2013;2013:698325
pubmed: 23984401
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
pubmed: 18462102
Environ Monit Assess. 2010 Sep;168(1-4):481-7
pubmed: 19697147
Biol Proced Online. 1998 May 14;1:40-47
pubmed: 12734590
Nihon Ishinkin Gakkai Zasshi. 2009;50(4):235-42
pubmed: 19942795
Sci Transl Med. 2012 Dec 19;4(165):165rv13
pubmed: 23253612
Indian J Med Microbiol. 2018 Jul-Sep;36(3):408-415
pubmed: 30429396
Clin Microbiol Infect. 2005 May;11(5):359-65
pubmed: 15819861
Clin Infect Dis. 2001 Jul 15;33(2):139-44
pubmed: 11418871
Ann Thorac Surg. 2002 Jan;73(1):306-8
pubmed: 11834038
J Clin Oncol. 2002 Apr 1;20(7):1898-906
pubmed: 11919250
Haematologica. 2006 Aug;91(8):1068-75
pubmed: 16885047
Indian J Med Microbiol. 2011 Apr-Jun;29(2):172-7
pubmed: 21654115
Iran J Public Health. 2012;41(7):70-6
pubmed: 23113213
Value Health. 2002 Jan-Feb;5(1):26-34
pubmed: 11873380
Respirology. 2012 Aug;17(6):913-26
pubmed: 22335254
Iran J Allergy Asthma Immunol. 2005 Mar;4(1):27-32
pubmed: 17301420
Am J Med. 1991 Oct;91(4):371-6
pubmed: 1951381
Eur J Clin Microbiol Infect Dis. 1996 Feb;15(2):139-45
pubmed: 8801086
BMC Biotechnol. 2004 Apr 21;4:8
pubmed: 15102338
J Microbiol Methods. 2004 Oct;59(1):141-6
pubmed: 15325762
N Engl J Med. 2012 Feb 2;366(5):454-61
pubmed: 22296079